Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Inhibition of Poly(ADP-ribose) polymerase activity accelerates T-cell lymphomagenesis in p53 deficient mice

Abstract

Cells that lack PARP-1 activity are limited in their ability to repair DNA single strand breaks and respond to DNA damage with a strong accumulation of p53 and enhanced rates of apoptotic cell death. We have generated combinatorial mutant mice that both lack p53 and PARP-1 activity due to the expression of a dominant negative PARP-1 allele targeted to T-cells by the lck promoter. Here we report that these double mutant mice develop T-cell lymphoma at a significantly reduced latency period compared to single p53 null mice that are already cancer prone. We demonstrate that the absence of p53 does not only protect T-cells from lck-PARP-DBD transgenic mice from apoptosis but also abrogates the DNA damage induced cell cycle arrest in the G1 phase. T-cells from double mutant mice continue to proliferate after the induction of DNA strand breaks, are limited in their DNA repair capacity and cannot be eliminated by apoptosis. These results indicate that PARP-1 and p53 cooperate in the suppression of tumorigenesis by maintaining genomic integrity after DNA damage through the activation of a G1/S cell cycle checkpoint the initiation of DNA repair and the induction of cell death.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Althaus FR, Hofferer L, Kleczkowska HE, Malanga M, Naegeli H, Panzeter PL, Realini CA . 1994 Mol. Cell. Biochem. 138: 53–59

  • Beneke R, Geisen C, Zevnik B, Bauch T, Müller WU, Küpper JH, Möröy T . 2000 Mol. Cell. Biol. 20: 6695–6703

  • Conde C, Mark M, Oliver FJ, Huber A, de Murcia G, Menissier-de Murcia J . 2001 EMBO J. 20: 3535–3543

  • Dantzer F, de La Rubia G, Menissier-De Murcia J, Hostomsky Z, de Murcia G, Schreiber V . 2000 Biochemistry 39: 7559–7569

  • Darzynkiewicz Z, Bruno S, DelBino G, Gorzyca W, Hotz MA, Lassota P, Traganos F . 1992 Cytometry 13: 795–808

  • de Murcia G, Menissier de Murcia J . 1994 Trends Biochem. Sci. 19: 172–176

  • de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, Walztinger C, Chambon P, de Murcia G . 1997 Proc. Natl. Acad. Sci. USA 94: 7303–7307

  • Deppert W . 1994 Semin. Cancer Biol. 5: 187–202

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS, Bradley A . 1992 Nature 356: 215–221

  • Enoch T, Norbury C . 1995 TIBS 20: 426–430

  • Hassa PO, Hottiger MO . 1999 Biol. Chem. 380: 953–959

  • Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA . 1994 Curr. Biol. 4: 1–7

  • Jackson SP . 1996 Curr. Opin. Genet. Develop. 6: 12–25

  • Jeggo PA . 1998 Curr. Biol. 8: R49–R51

  • Joshi VV, Frei JV . 1970 J. Natl. Cancer Inst. 44: 185–208

  • Karsunky H, Geisen C, Schmidt T, Haas K, Zevnik B, Gau E, Möröy T . 1999 Oncogene 18: 7816–7824

  • Krammer PH . 2000 Nature 407: 789–795

  • Küpper JH, de Murcia G, Bürkle A . 1990 J. Biol. Chem. 265: 18721–18724

  • Küpper JH, Müller M, Bürkle A . 1996 Cancer Res. 56: 2715–2717

  • Küpper JH, Müller M, Jacobson MK, Tatsumi-Miyajima J, Coyle DL, Jacobson EL, Bürkle A . 1995 Mol. Cell. Biol. 15: 3154–3163

  • Lakin ND, Jackson SP . 1999 Oncogene 18: 7644–7655

  • Levine AJ . 1997 Cell 88: 323–331

  • Lindahl T, Satoh MS, Poirier GG, Klungland A . 1995 TIBS 20: 405–411

  • Liu L, Allay E, Dumenco LL, Gerson SL . 1994 Cancer Res. 54: 4648–4652

  • Molinete M, Vermeulen W, Bürkle A, Menissier-de Murcia J, Küpper JH, Hoeijmakers JH, de Murcia G . 1993 EMBO J. 12: 2109–2117

  • Möröy T, Grzeschiczek A, Petzold S, Hartmann KU . 1993 Proc. Natl. Acad. Sci. USA 90: 10734–10738

  • Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M, Krammer PH . 1998 J. Exp. Med. 188: 2033–2045

  • Newton K, Strasser A . 2000 J. Exp. Med. 191: 195–200

  • Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G . 1999 EMBO J. 18: 4446–4454

  • Oren M . 1999 J. Biol. Chem. 274: 36031–36034

  • Panzeter PL, Zweifel B, Malanga M, Waser SH, Richard M, Althaus FR . 1993 J. Biol. Chem. 268: 17662–17664

  • Samper E, Goytisolo FA, Menissier-de Murcia J, Gonzalez-Suarez E, Cigudosa JC, de Murcia G, Blasco MA . 2001 J. Cell. Biol. 154: 49–60

  • Schreiber V, Hunting D, Trucco C, Gowans B, Grunwald D, De Murcia G, De Murcia JM . 1995 Proc. Natl. Acad. Sci. USA 92: 4753–4757

  • Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ . 1991 Cell 68: 879–888

  • Sofer-Levi Y, Resnitzki D . 1996 Oncogene 13: 2431–2437

  • Tong WM, Hande MP, Lansdorp PM, Wang ZQ . 2001 Mol. Cell. Biol. 21: 4046–4054

  • Trucco C, Oliver FJ, de Murcia G, Menissier-de Murcia J . 1998 Nucleic Acids Res. 26: 2644–2649

  • Tsutsumi M, Masutani M, Nozaki T, Kusuoka O, Tsujiuchi T, Nakagama H, Suzuki H, Konishi Y, Sugimura T . 2001 Carcinogenesis 22: 1–3

  • Van Meyel DJ, Sanchez-Sweatman OH, Kerkvliet N, Stitt L, Ramsay DA, Khokha R, Chambers AF, Cairncross JG . 1998 Int. J. Oncol 13: 917–922

  • Walczak H, Krammer PH . 2000 Exp. Cell. Res. 256: 58–66

  • Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF . 1995 Genes Dev. 9: 509–520

Download references

Acknowledgements

This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Mo 435/9-3), the IFORES-Program of the University of Essen Medical School and the ‘Fond der chemischen Industrie’.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tarik Möröy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beneke, R., Möröy, T. Inhibition of Poly(ADP-ribose) polymerase activity accelerates T-cell lymphomagenesis in p53 deficient mice. Oncogene 20, 8136–8141 (2001). https://doi.org/10.1038/sj.onc.1205056

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205056

Keywords

This article is cited by

Search

Quick links